CD1A and neoplasm: In a study of tumor cells from 48 DLBCL patients, it was found that in 21% of patients, there was an increased number of CD1a+ dendritic cells at the tumor margins, and this was significantly correlated with a favorable prognosis (p = 0.015) (Chang et al., 2007).